Toxicology Letters

Article	Citations
S05-03 The development of a human liver-based In Vitro test battery to detect liver steatotic potential of chemicals from various applicability domains	56
P02-46 Cultivation conditions in microfluidic environments: insights from 2D and 3D cell culture models	46
P01-39 Mitochondrial toxicity screening to support the R&D crop protection pipeline	38
P07-09 Spatio-temporal multi-omics analysis of lung tissue and matched biofluids identifies circulatory safety biomarkers for monitoring inhaled drug induced lung injury	34
P02-47 A rat in vitro 3D airway model for translational toxicology	33
S20-04 Generic pharmacokinetic models for mother-to-offspring transfer of environmental chemicals	32
P09-10 The synthetic cannabinoid ADB-FUBINACA disrupts mitochondrial biogenesis of NG108-15 neuroblastoma cells during neuronal differentiation at human-relevant concentrations	31
P02-26 Optimized iPSC-derived hepatocytes offer a novel liver cell model for in vitro predictive toxicity and drug efficacy studies	30
P12-13 Role of endoplasmic reticulum stress in sunitinib-induced hepatotoxicity	30
P08-03 Comprehensive digital documentation and computer-assisted evaluation of the skeleton of Alizarin Red and Alcian Bluestained rat foetuses	29
P17-07 Prenatal exposure to acrylamide and metabolic status at 20 years of age: a prospective biomarker-based cohort study from Denmark	28
P21-54 Searching for links in binding patterns among androgen and progesterone receptor ligands	27
P07-18 Acute phase proteins in Göttingen minipigs: comparison between haptoglobin, Pig-MAPP and CRP in the context of a vaccine study	26
P07-05 Miniaturization of haematology sampling in rodents on toxicology studies	26
The toxicology of inhaled nanomaterials and examples of risk assessment and regulation	26
P19-50 In-chemico reactivity methods based on molecular initiating event of skin sensitization: refinements and possible application to cosmetic formulations	26
P14-06 The cytotoxicity of bortezomib in AC16 cardiac cells and possible therapeutic options involving Nrf2	24
P08-10 Advancing the use of New Approach Methodologies for assessing teratogenicity using a tiered approach: metabolism consideration to improve the human relevance	23
P02-22 Establishment of a microfluidic neurotoxicity screening model using human iPSCs-differentiated motor neurons within the New Approach Methodologies for chemical safety developed for Precision To	23
P13-36 In silico analysis of positive and negative effects of isothiocyanates in breast cancer	21
P06-04 Advancing bladder cancer detection: unveiling a novel urinary biomarker panel through metabolomics	21
P20-27 Zinc suphide – considerations and challenges for acute inhalation toxicity testing and classification under REACH	21
P19-03 Integration of transcriptomics data for ED assessments using an Adverse Outcome Pathway Network approach	21
Toxicokinetic relationship between the adducts in globin and their cleavage products in the urine: Implications for human biomonitoring	20
Exosomal miR-196b secreted from bronchial epithelial cells chronically exposed to low-dose PM2.5 promotes invasiveness of adjacent and lung cancer cells	20

LP-10 Comparative analysis of occupational exposure limits (OELs) for inhibiting RNA therapeutics	20
P22-02: The Renal Proximal Tubule TXG-MAPr: Safety Assessment Based On Quantitative Gene Network Analysis	19
S23-02 Assessment and modelling of metabolites: the conazole case study	19
LP-17: Evaluation of Genistein as a Mitochondrial Modulator and its Effects on Sperm Motility	19
KL02 | EUROTOX Lecture Award	19
P17-36: Ti-alloy (TiAl6Nb7) metal powder toxicity in human embryonic kidney (HEK-293T) cell line	19
OS03-10: Predictive Modeling of Deltamethrin Exposure in Fetal Brain Tissue: Implications for Human Health Risk Assessment	18
P09-46: Preliminary results of the second National Human Biomonitoring program in Slovenia: bisphenols, parabens, PFAS, glyphosate and trace elements in children and adolescents	18
P19-05: Comparison of in vitro and in vivo study results for classification of plant protection products	18
S12A-03: Occupational exposure to copper in dust: Chemical characterization and impact on regulation	18
P09-34: Unraveling hormonal dependencies and associated species-specificities of neurodevelopmental key events to improve EDC risk assessment	18
P23-05: Urinary monohydroxyl-polycyclic aromatic hydrocarbons and metals in firefighters with active participation in controlled structure fires	18
P22-35: Mapping of DNT NAMs’ signaling pathways in human physiology and disease for regulatory application	17
P10-09: Toxicological aspects of the Horizon EDIAQI project	17
P08-18 Predicting non-genotoxic carcinogenic potential of agrochemicals: a mechanistic approach	17
P13-07: High-dimensional profiling of immune response to vaccines using bio-stabilized and injectable natural human skin	17
P08-21 Lack of genotoxicity of Rhamnus Purshiana, Sennae Fructus, and Rhamnus Frangula in a micronucleus assay in vitro (OECD 787)	17
S09-03: NAMs in DART testing of pharmaceuticals under ICHS5(R3)	17
P25-13: Polo-like kinase 4 (PLK4) Safety Review – distilling the risks with a rapid augmented intelligence approach	17
P22-31: Training the next-generation toxicologists	17
P19-07 Dermal occupational exposure assessment – comparison of selected modeling tools	17
P13-07 Addition of physiologically relevant conditions has the potential to effect the toxicology of engineered nanomaterial hazards in an in vitro co-culture of the alveolar region of the lung	16
SOC-I-06 Differentially expressed microRNAs in human bronchial epithelial cells after exposure to nanofibrillar, microfibrillar or nanocrystalline cellulose	16
P19-08 New values of occupational exposure limits (OELs) of inhalation anesthetics: enflurane, isoflurane, sevoflurane and desflurane in Poland	16
P03-03 Autopsy findings and toxicological results in Khat-related fatalities in Jazan, Saudi Arabia	16
P17-26 Assessment of anabolic steroids impact on 5β-reductase by virtual screening and in vitro approaches	16
P21-17 Risk assessment of chemicals in the Dutch red meat production chain	16
LP-40: Non-clinical Safety profile of a new i.v. Formulation of Rifabutin (BV100) – an Opportunity for new Treatments	16
P08-15 Assessing of in vitro genotoxicity testing strategy for T-2 mycotoxin	16
CEC07-03 Towards internal threshold of toxicological concern (iTTC): Implementation of Pharmacokinetics (PK) in the safety assessment	16
P03-21 Magic mushrooms and psilocybin: pharmacokinetics, pharmacodynamics, and clinical applications	15
P05-06 Protective role of peroxiredoxin V against UVB-induced apoptosis of epidermal keratinocytes	15
P16-01 Silver nanoparticles suppressed retinoic acid-induced neuronal differentiation in SH-SY5Y cells	15
Reviewers	15
P06-22 Reproductive and developmental toxicity testing of a complex UVCB: implications of current dose setting advice under REACH for generating meaningful study outcomes	15
P16-05 Influence of the new potential antidepressant SMe1EC2M3 treatment on neuronal outgrowth and arborization	15
S11-01: A regulatory perspective: hazard identification and potency classification	15
S-29-02 Assessing the risk of mitochondrially active compounds in medicines development	15
P22-17 Acrylamide exposure estimates in the EuroMix biomonitoring study using a probabilistic approach	14
P08-08 Toxicogenic effects of leaf extracts from an Andean medicinal plant	14
P22-16: Heated tobacco and e-vapour products induce lower biological activity compared to cigarettes using the ToxProfiler assay	14
P14-04 Compartmental toxicokinetic model for urinary excretion of cleavage products resulting from adducts with globin	14
S-17-02 Prioritization of contaminants for evaluation in food by WHO/FAO expert committees	14
LP-27: Combination of air- and biomonitoring to control cadmium exposure at the workplace	14
P21-31 Criteria for selecting physiologically-based kinetic models for use in developing new models for data-poor analogues via a read-across approach	14
P04-19 Selecting drug like structures using in silico tools	14
S-03-02 Development of T2 MRI biomarker of neurotoxicity as a noninvasive quantitative approach	14
PL04-01 Challenges and opportunities for regulatory toxicology under the chemicals strategy for sustainability	13
P33-06 Disruption of the plasma membrane organization and neuroinflammation can be triggered by toxic organophosphorus compounds	13
P09-14 Health Impact of PM2.5 on Pregnant women and Children: Systematic Review	13

P28-20 Challenges and Best Practices in Conducting Multigenerational Studies: A CRO Perspective	13
LP-46: Counterfeit drugs awareness among a Mexican sample: An underappreciated health risk	13
P22-24 Polystyrene nanoplastics induced cognitive impairment through dysregulation of autophagy and synaptic plasticity in rats	13
Are electric vehicles actually bad for the environment?	13
S04-03 Sponsor Perspectives on Implementing WOE Approaches	13
S-01-03 Integrating in vitro distribution kinetics analysis in IVIVE-PBK	13
P17-27: Role of oxidative stress in microplastic polymethyl methacrylate (PMMA)-induced hepatotoxicity with HepG2/THP-1 co-culture model	13
S13-02 NAMs to investigate chemical-induced immunotoxicity: the cases of PFAS and BPA analogs	13
P09-11 The disruption of the human astrocytic cell cycle by hexavalent chromium	13
P09-33 Oxidative Potential of Traffic-Derived Ultrafine Particles and Their Impact on Olfactory Mucosa Cells in Alzheimer's Disease	12
S02-01 Probabilistic Risk Assessment in Practice	12
P29-11 A delayed activation of p38 MAPK in dendritic cells distinguishes respiratory from skin sensitizers	12
OS01-08 Activity-based characterization of New Psychoactive Substances (NPS): a forgotten technology with new forensic applications	12
S27-03 The microbiome modifies neurobehavior in zebrafish exposed to Aryl Hydrocarbon Receptor (AHR) modulators	11
P14-07 Outcome of the re-assessment of the risks to public health related to the genotoxicity of styrene present in plastic food contact materials	11
CEC04-05 Feasability of quality criteria and tentative assessment tools to align with artificial intelligence	11
S13-04 Skin sensitization potency assessment: Make full use of NAM data to conduct quantitative risk assessment	11
Comparative effects of e-cigarette and conventional cigarette smoke on in vitro bronchial epithelial cell responses	11
Lysosomal membrane permeabilization mediated apoptosis involve in perphenazine-induced hepatotoxicity in vitro and in vivo	11
P23-08 Importance of Buccal Micronucleus Assay in the Biomonitoring of DNA Damage in Paint Workers	11
P23-11 RVG-modified sEVs selectively delivers BDNF to brain, promotes neurogenesis and mitigates Parkinson-like symptoms	11
P07-07 Investigation of the Endocrine Disrupting Effects of Lilial	11
S08-02 Current and emerging concepts of cardiotoxicity: applicability inrisk assessment for regulatory purposes	11
P11-01 BPS and BPF by acting as mitochondrial disrupting chemicals cause changes in energy metabolism in human ovarian granulosa cells	11
Inhibition of placental 11β-HSD2 expression through cAMP/PKA signaling pathway induces intrauterine growth retardation	11
P23-14 Heavy Metals: Toxicity and Renal Damage	11
P31-33 Classification based risk assessment in the safety evaluation of Extractables & Leachables	11
S24-02 Studying and comparing the role of time in in vitroand in vivotoxicity tests	11
P12-26 Effect of ketogenic diet on the metabolism of ozanimod in mice	11
P24-11 Waiving of the dog studies in the regulatory process of agrochemicals approval	11
Evaluating applicability domain of acute toxicity QSAR models for military and industrial chemical risk assessment	11
circ_0000554 promotes macrophage M2 polarization mediated by glycolytic reprogramming and aggravates COPD injury	11
P02-30 Generation and evaluation of a historical control database for the creation of assay acceptance criteria for a comparative in vitro hepatic enzyme assay	10
A critical review of microplastics toxicity and potential adverse outcome pathway in human gastrointestinal tract following oral exposure	10
Comparative toxicity of eleven bisphenol analogs in the nematode Caenorhabditis elegans	10
A battery of assays for chasing ricin and its activity	10
Gentamicin administration leads to synaptic dysfunction in inner hair cells	10
Advances in understanding the neurotoxicity of lead, cadmium, arsenic, and therapeutic strategies	10
Non-alcoholic fatty liver disease changes the expression and activity of hepatic drug-metabolizing enzymes and transporters in rats	10
The suitability of a polydimethylsiloxane-based (PDMS) microfluidic two compartment system for the toxicokinetic analysis of organophosphorus compounds	10
Effects of chlorpyrifos on transient receptor potential channels	10
Enhancement of cigarette smoke extract-induced goblet cell metaplasia and hyperplasia exerted through IL-13 receptor α1 expression	10
The mouse Anxa6/miR-9-5p/Anxa2 axis modulates TGF-β1-induced mouse hepatic stellate cell (mHSC) activation and CCl4-caused liver fibrosis	10
Cigarette smoke extract mediates cell premature senescence in chronic obstructive pulmonary disease patients by up-regulating USP7 to activate p300-p53/p21 pathway	10
Evidence for adduction of biologic amines with reactive metabolite of 8-epidiosbulbin E acetate in vitro and in vivo	10
Toxicity prediction using target, interactome, and pathway profiles as descriptors	10
Copper exposure at a daily dose twice the recommended in diabetic rats induces oxidative stress, vascular dysfunction and perivascular adipose tissue inflammation in diabetic rats	10
Individual and mixed effects of PFAS on osteoporosis: Insights from epidemiological and bioinformatic approaches	10
Skin penetration and decontamination efficacy following in vitro human skin exposure to sulfur mustard	10
The harmful acute effects of clomipramine in the rat liver: Impairments in mitochondrial bioenergetics	10
The MIR100HG/miR-29a-3p/Tab1 axis modulates TGF-β1-induced fibrotic changes in type II alveolar epithelial cells BLM-caused lung fibrogenesis in mice	10
The relative efficacy of chemically diverse small-molecule enzyme-inhibitors against anticoagulant activities of Black Snake (Pseudechis spp.) venoms	9
S24-02 Biomarkers of neurodevelopmental effect can reduce uncertainty when assessing the risks of thyroid disrupting chemicals	9
CEC04-02 Comparison of outdoor and indoor air pollution on cardio-pulmonary health	9
P26-02 Ensuring pharmaceutical packaging safety: an integrated approach for assessing extractable profiles and toxicological risk	9
P21-56 Shedding light on the epidermal alterations induced by blue light and heated tobacco products co-exposure: an in vitro study	9
S23-04 RapidTox: decision-based workflow environment to advance human health assessment	9
Do urinary metabolites reflect occupational exposure to organophosphate flame retardants? A case study in electronic waste recycling workers.	9
Binding of ligands to the aryl hydrocarbon receptor: An overview of methods	9
P25-07 Do co-formulants influence PPP genotoxicity? – a case study	9
S23-01 The ASPIS-initiated Safety Profiling Algorithm (ASPA): setting the stage for Next-Generation Risk Assessment	9
P19-32 Advancing the application of New Approach Methodologies (NAMs) in systemic toxicity assessment of cosmetic ingredients: insights from cosmetics Europe long range science strategy (2016–2022) ca	9
Title Page	9
P03-03 Quantitative in vitro to in vivo extrapolation (QIVIVE) for liver-induced thyroid toxicity risk assessment	9
P02-18 Using individual-centric model to detect immune-mediated idiosyncratic drug-induced liver injury at preclinical stage	9
BDE-47 induces metabolic dysfunction-associated steatotic liver disease (MASLD) through CD36-mediated increased fatty acid uptake and PPARα-induced abnormal fatty acid oxidation in BALB/c mice	9
P01-62 Development of an in vitro model of dry nose	9
P17-03 Toxic and essential metals in breast milk: Preliminary results from Bosnia and Herzegovina	9
P19-26 Moving towards a framework for in vitro risk assessment and determination of human relevance of rodent liver-mediated thyroid toxicity	9
CEC01-01 Introduction into the AOP framework: Integrating Theory and Practice in AOP Development	9
OS02-03 Using a systems biology approach to construct adverse outcome pathway networks aligned with the FAIR principles	9
In vitro/in silico prediction of drug induced steatosis in relation to oral doses and blood concentrations by the Nile Red assay	9
P13-03 Comparative study of mutagenic/antimutagenic and genotoxic/antigenotoxic activities of ethanolic and aqueous extracts prepared from Arbutus unedo fruits	8
P17-21 Effects of early-life BPA analog exposure on natural killer cell function and development	8
P23-11 Assessment of PAH exposure in trainee firefighters using a PAH CALUX bioassay	8
Endocrine disruptors and microplastics: facing complexity with connection	8
P18-15 Determination of tramadol and its metabolite O-desmethyltramadol in blood and vitreous humor samples	8
P31-18 Protective Effects of N-Acetylcysteine and Coenzyme Q10 Against Atorvastatin-Induced Myopathy and Oxidative Damage	8
P23-12 Updating Finnish biomonitoring reference values and health-based guidance values for occupational exposure and risk assessment of selected metals	8
P21-12 Investigating the hematotoxic effects of the mixture of lead and polychlorinated-biphenyls by combining in vivo and in silico approach	8

CEC01-03 The current biological understanding of the respiratory tract, the in vitro models available as well as their use	8
P19-26 Assessment of hepatotoxicity induced by heat-not-burn cigarette extract using various types of hepatocytes	8
P01-63 The secretion of interleukin 18 by reconstructed human epidermis is a biomarker for in vitro prediction of skin photosensitization	8
S02-04 Computational Toxicology in Drug Safety	8
S12-06 Finding European research funding and writing a competitive research proposal	8
P24-15 Targeted groundwater monitoring for plant protection products and their metabolites in agricultural regions of Slovenia	8
S16-03 Microbial pesticides: a regulatory overview	8
P17-13 Optimization of Macrophage Polarization and Phagocytosis Assays for Immunotoxicology Studies	8
S05-03 Shear forces affect cell differentiation and cell sensitivity in organs-on-chip models	8
P18-62 Mechanistic Insights of BPA Alternatives on PPARγ Binding and Consequences on Adipocyte Differentiation	8
P03-01 Harnessing the power of AI to drive organ-level toxicity predictions	8
P09-18 Comprehensive search for genes that vary across three developmental neurotoxicants	8
P17-04 Unveiling the Hidden Threat: Genotoxicity and Oxidative Stress Induced by Microplastics in Human Health and Immune Disorders	8
P20-14 The effect of non-functionalized polystyrene nanoparticles with varying diameters on human albumin (in vitro)	8
P22-46 Effects of plastic nanoparticles, paracetamol, ibuprofen and their mixtures on steroidogenesis in vitro	8
LP-22 In vitro Metabolite Profiling of CF3-Etomidate: A New Etomidate Analogs	8
P18-64 Ring trial validation of a cell-based RAR transactivation method	8
P30-59 Interest of the Micronucleus test on Reconstructed Skin and skin organoids for cosmetic products	7
P11-02: Online methods and tools for assessing chemical exposure in humans: a systematic scoping review for the ONTOX project	7
P22-02 Cytotoxic and genotoxic effects induced by aluminium oxide nanoparticles on TM3 Leydig cells	7
P04-06: Toxicity of particulate matter from experimental burning of domestic waste	7
P23-03: Applying the Multiple Path Particle Dosimetry model for assessing Occupational Exposure to Active Pharmaceutical Ingredients	7
P22-08: New strategies for the safety assessment of proteins in food/feed derived from biotechnology – the way forward	7
P16-21: Applications of an isogenic human iPSC-derived blood-brain barrier (BBB) model	7
Spilled liquid mercury: Case studies, proposition of safety procedures with assessment of commercial cleanup kit and recommendations	7
P28-22 Identification of candidate molecular markers for detection of abnormal Mullerian duct morphology in male Japanese quail embryos exposed to estrogenic substances	7
P14-36 Development and optimization of flow cytometry driven analysis of micronucleus in vitro using 3D skin tissues	7
CEC06-03: Documenting pesticide exposures from field studies: what is known and why we should know more	7
S17-02 OASIS Consortium: Strategies for detecting in vivohepatotoxicity with in vitro‘omic technologies	7
P26-11: Acute and subacute toxicity profiles in Sprague-Dawley (SD) rats treated with Piperis Longi Fructus (PLF) Powder	7
CEC01-01: A hands-on introduction to applied artificial intelligence in toxicology	7
P17-09: Polystyrene microplastics of varying sizes and shapes induce distinct redox and mitochondrial stress responses in a Caco-2 monolayer	7
P25-05: Media representation of Glyphosate in Slovenian Printed Media over 10 year period	7
S13-01: How far are we with the implementation of NGRA for cosmetics?	7
Harmful beauty – Temporal profile of urinary phthalate metabolites in tattooed volunteers from Slovakia	7
P33-05 Preliminary Toxicological Evaluation of Four Candidate Radiosensitizers in Sprague-Dawley Rats	7
Editorial Board	7
P18-78 What does new nitrosamine data reveal about the CPCA framework?	7
P10-03: Cadmium levels are related to clonal hematopoiesis and mortality	7
P08-15 Evaluation of nanoatrazine bioaccumulation in green microalga Raphidocelis subcapitata: characterization, stability and uptake analysis	7
P01-02: An updated adverse outcome pathway network on chemical-induced liver steatosis	7
P22-11: Case study of resveratrol as a cosmetic ingredient for systemic toxicity using the new approachmethodologies of next generation risk assessment	7
P10-25: Cytotoxic and genotoxic effects of particulate matter emitted in beauty salons	7
P22-03: Read-Across case study – from hypothesis to regulatory acceptance	7
Editorial Board	7
miR-520f-3p blocks MNNG-induced gastric precancerous lesions via the KLF7/NFκB pathway	6
LP-04: Adverse Outcome Pathways of Toxicity-Induced Dry Eye: implication of ferroptosis and pyroptosis in corneal neuroepithelial entity	6
P11-26 Exosomes derived from primed mesenchymal stem cells improve cell viability on an APAP-induced hepatic injury in vitro model	6
PPARγ activation inhibits endocytosis of claudin-4 and protects against deoxynivalenol-induced intestinal barrier dysfunction in IPEC-J2 cells and weaned piglets	6
Adefovir accumulation in the renal interstitium triggers mast cell degranulation and promotes renal interstitial fibrosis	6
S-05-02 How can grouping and read-across support safe(r)-by-design of nanomaterials and advanced materials? GRACIOUS	6
Analysis of structure phototoxicity relationship towards the de-risking of phototoxic liabilities in early drug discovery	6
P22-11 Current challenges in water quality require advanced risk assessment	6
S-26-01 Methylmercury-induced modification of selenocysteine in selenoprotein P – Implication to its physiological function	6
P04-16 In silico applications for the prediction and hazard assessment of transformation products originated from water disinfection treatment processes	6
P11-05 Toxic microelements levels in the blood clot of wild boar (Sus scrofa) for monitoring the contamination and biomarkers changes	6
P08-12 The surfactant co-formulant POEA in the glyphosate-based herbicide RangerPro but not glyphosate alone causes necrosis and ER stress in mammalian cell lines	6
P03-22: Sensitivity of primary human hepatocytes and HepG2 cells for genotoxicity testing of N-nitrosamines in the in vitro alkaline comet assay	6
P06-40: Integrating physiologically-based pharmacokinetic modelling and 'omics data to derive a health-based guidance value for perfluorooctanoic acid	6
P22-27 Exposure assessment of total DON in urine of Portuguese adult population under the HBM4EU aligned studies	6
LP-37 Biokinetics of fluorophore-conjugated microplastics in marine mussels	6
Toxicokinetic analysis of the highly toxic nerve agent VX in commercially available multi-organ-chips – Ways to overcome compound absorption	6
P12-32 An all-human cell based tri-culture system distinguished through morphology, longevity, and functionality	6
P12-59 Assessing the placental transfer of dexamethasone via ex vivo human placenta perfusions: a step-up towards model informeddrug dosing in pregnancy	6
P16-17 The senescence-associated secretory phenotype (SASP) from colorectal cancer cells induce neurotoxicity: novel mechanism involvement of CD38-NAD+ pathways	6
P17-12 Molecular network pathway analysis of arsenic and cisplatin in cancer	6
KL06 | Keynote Lecture	6
P03-04 Validation of an analytical method to identify and quantify selected amphetamine-related drugs (ARDs) in whole blood (WB) using UPLC-qTOF-MS after extraction by MMSPE	6
P17-30: Amorphous silica nanomaterials effects on human dendritic cells promote the T-cell response to the pneumallergen Bet v 1a	6
P01-04: Development of an Adverse Outcome Pathway (AOP) to assess the neurotoxicity of the exposure to benzo(a)pyrene	6
P22-05 Identification and hazard assessment of oligoesters, nonintentionally added substances present in food contact coating extracts	6
LP-20 Halogen-free flame retardant is friendlier to the aquatic environment than PBDEs	6
LP-23 Molecular glue degrader reproductive toxicity: what did we learn?	6
P10-12 Investigation of the effects of endocrine disruptors on T cells differentiation	6
S-31-01 Setting the scene: human health impacts of micro- and nanoplastics (MNPs)	6
P12-08 Biological evaluation of pharmaceuticals inhibiting 11β-hydroxylase identified by virtual screening	6
Corrigendum to “Furocoumarins affect hepatic cytochrome P450 and renal organic ion transporters in mice” [Toxicol. Lett. 209 (2012) 67–77]	6
P21-16 Cytotoxicity: regulatory definitions versus scientific knowledge	6
P09-26: Methods for the assessment of deiodinases inhibition by thyroid hormone disrupting chemicals and environmental pollutant mixtures	5
CEC05-04: The systemic effects of nano-size particles: lessons from the cardiovascular system	5
P24-31: The Human Health dataset of the approved biocidal active substances	5
S21-02: The Halifax Project 10 years later: what we've learned and what we are still missing on the cumulative carcinogenic effect of environmental chemicals	5
S12-01: Physiologically-Based Kinetic (PBK) Models and Applications In Read-Across	5
P24-25: Comparative Pharmacokinetics and Safety Assessment of Nanocrystal Formulated Zileuton at the Gastrointestinal Tract Reveals Sex-Dependent Mucosal Immune Response, Epithelial Permeability and D	5
P24-06: Applicability of the DPRA on mixture testing: Challenges and opportunities	5
P23-09: Filling in safety data sheets for data-poor substances relevant to drug development	5
OS02-05: Genotoxicity in peripheral blood leukocytes and reticulocytes of e-waste management workers	5
CEC01-04: Toxicogenomics data and analysis workflows	5
P21-34 SARS-CoV-2 omicron infection aggravates lung fibrosis through IL6/ CSF/ RANTES activation and dysfunction of lipid metabolism in mice with PHMG-induced lung injury	5
LP-25: The curious case of Adverse Outcome Pathways: the stressor agnostic approach bridging disciplines by embracing evidence from diverse initiating factors	5
P09-19: Evaluation of new alternative methods to endocrine disruption: a comparison of in vitro and in silico results	5
P03-21: Genotoxicity and mutagenicity assessment of sediment samples from the Stolberg area in Western Germany following the extreme flood event in 2021	5
P08-05: 3D microphysiological placenta in-vitro model as a tool for drug transport studies and risk assessment	5
TP induces hepatic intolerance to FasL-mediated hepatocyte apoptosis by inhibiting XIAP	5
S22-02: In vitro assessment of immunotoxicity with a focus on immunosuppression	5